Replicate Bioscience
Latest round
- Series A
Last raised
- Sep 2021
Total raised
- $40M
Investors
- 1
About Replicate Bioscience
Founded in 2020 and based in California, US, Replicate Bioscience, Inc. operates as a biopharmaceutical company that designing and delivering srRNA immunotherapies to revolutionize the practice of medicine to treat patients with cancer diseases.
Who invested in Replicate Bioscience
1 investor across 1 round
See all investors in Replicate Bioscience
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Sep 8, 2021
Amount
$40M
Investors
Questions about Replicate Bioscience
Who invested in Replicate Bioscience?
Replicate Bioscience has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Replicate Bioscience raised?
Replicate Bioscience has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Replicate Bioscience last raise money?
Replicate Bioscience's most recent round on record is a Series A, in Sep 2021.
What does Replicate Bioscience do?
Founded in 2020 and based in California, US, Replicate Bioscience, Inc.
Where is Replicate Bioscience headquartered?
Replicate Bioscience is headquartered in San Diego, US.
Which VCs invest in companies like Replicate Bioscience?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Replicate Bioscience's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Replicate Bioscience? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.